| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Total non-operating income (expense), net | -3,349 | -3,165 | -2,703 | |
| Loss before provision for income taxes | - | - | -37,048 | |
| Loss before provision (benefit) for income taxes and equity method investment | -35,021 | -39,395 | - | |
| Provision (benefit) for income taxes | -33 | -188 | 9 | |
| Loss before equity method investment | -34,988 | -39,207 | - | |
| Loss from equity method investment | -534 | -2,386 | - | |
| Net loss | -35,522 | -41,593 | -37,057 | |
| Earnings per share, basic, total | -1.87 | -2.95 | -0.18 | |
| Earnings per share, diluted, total | -1.87 | -2.95 | -0.18 | |
| Weighted average number of shares outstanding, basic, total | 18,946,559 | 14,087,307 | 209,249,000 | |
| Weighted average number of shares outstanding, diluted, total | 18,946,559 | 14,087,307 | 209,249,000 | |
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)